Why Choose Dr. Pass?
Dr. Harvey Pass has served as Director for the Thoracic Surgery Division of New York University (NYU). He has also helped solidify NYU’s thoracic surgery fellowship program and its thoracic surgery research program. This research program is funded by the National Cancer Institute as an Early Detection Research Network Biomarker Discovery Laboratory.
Dr. Pass currently serves as a thoracic surgeon and Principal Investigator at NYU. His special areas of interest include the absestos-related cancers of lung cancer and mesothelioma.
Dr. Harvey Pass was one of the first investigators to study intraoperative photodynamic therapy for the treatment of malignant pleural mesothelioma.
Dr. Pass was one of the first investigators to study intraoperative photodynamic therapy for the treatment of malignant pleural mesothelioma. He has collaborated on mesothelioma and lung cancer studies with Dr. Renato Baserga and Dr. Michele Carbone. His current research focuses on the use of biomarkers to aid in the early detection, diagnosis, and prognosis of these asbestos-related malignancies.
Dr. Pass remains a diehard advocate for raising awareness of asbestos-related diseases and supporting individuals with these diseases. He works to warn his patients and the general public about the dangers of asbestos exposure. He continues to provide his patients with the latest advances in the diagnosis and treatment of mesothelioma and lung cancer.